Harrow Inc. HROW
$38.62
▼ -0.03% 24H
About
Harrow Inc. is an eyecare pharmaceutical company focused on discovering, developing, and commercializing ophthalmic pharmaceutical products for the U.S. market. The company operates through two primary business segments: The Branded segment, which includes FDA-approved ophthalmology pharmaceutical products such as IHEE…
SectorHealthcare
ExchangeNASDAQ
IndustryDrug Manufacturers - Specialty & Generic
CountryUnited States
Employees373
TickerHROW
Statistics
Market Cap$1.44B
Revenue (TTM)$272.3M
Net Income-$5.1M
Net Margin-1.9%
EPS$-0.14
P/E-268.79
P/S5.22
P/B48.90
EV/EBITDA41.37
ROE-35.4%
Dividend Yield—
Price$38.62
Data: Twelve Data · Revenue = mcap / P/S